Bowel Diseases, Inflammatory Clinical Trial
Official title:
A 2-Cohort Study to Evaluate the Absolute Bioavailability, Absorption, Distribution, Metabolism and Excretion of TD-1473 Following an Intravenous and an Oral Dose of [14C]-TD-1473 in Healthy Male Subjects
This is an open-label, 2-cohort study to evaluate the absolute bioavailability, absorption, distribution, metabolism and excretion of TD-1473 in healthy male subjects. Subjects in cohort 1 will receive a single oral dose of TD-1473 and a single intravenous bolus dose of [14C]-TD-1473. Subjects in cohort 2 will receive a single oral dose of [14C]-TD-1473 only.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00640809 -
Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole
|
Phase 4 | |
Completed |
NCT04587713 -
Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
|
Phase 1 | |
Completed |
NCT05043363 -
LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19
|
||
Completed |
NCT02799615 -
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
|
||
Not yet recruiting |
NCT02760940 -
Anemia in Inflammatory Bowel Disease
|
Phase 4 | |
Terminated |
NCT04032756 -
Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
|
||
Terminated |
NCT02255227 -
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
|
Phase 2 | |
Completed |
NCT03999294 -
Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease
|
N/A |